https://biosciencetechnology.com/news/2012/10/medtronic-stent-successfully-treats-long-lesions-and-small-vessels-two-characteristics-typical-patients-diabetes-multiple-studies

https://biosciencetechnology.com/news/2012/10/brunswick-corporation-brunswick-awards-28-scholarships-children-brunswick-dealership-employees

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-23rd-aapl-acom-amcx-amgn-apd-aria-bhi-bidu-bkcc

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-23rd-svu-t-tdg-too-tss-txn-ual-vasc-vno

https://biosciencetechnology.com/news/2012/10/techne-1q-profit-down-strong-dollar-hurts-sales

https://biosciencetechnology.com/news/2012/10/medtronic-fortifies-spinal-interbody-portfolio

https://biosciencetechnology.com/news/2012/10/waters-3q-income-declines-after-sales-slip

https://biosciencetechnology.com/news/2012/10/omnicare-specialty-care-groups-acs-expands-orlando-operations

https://biosciencetechnology.com/news/2012/10/geron-announces-conference-call-discuss-third-quarter-2012-financial-results

https://biosciencetechnology.com/news/2012/10/two-year-follow-symplicity-htn-1-data-confirms-significant-and-sustained-blood-pressure-reduction-expanded-cohort-patients

https://biosciencetechnology.com/news/2012/10/propthink-line-earnings-are-good-enough-more-qcor-upside

https://biosciencetechnology.com/news/2012/10/cel-sci-clears-critical-phase-iii-safety-data-review-independent-monitoring-committee

https://biosciencetechnology.com/news/2012/10/propthink-nuvo-and-galderma-win-fda-approval-pliaglis-topical-peel

https://biosciencetechnology.com/news/2012/10/nearly-half-us-adults-high-blood-pressure-have-it-under-control

https://biosciencetechnology.com/news/2012/10/watson-sells-stake-latin-american-drugmaker

https://biosciencetechnology.com/news/2012/10/osiris-therapeutics-names-new-coo

https://biosciencetechnology.com/news/2012/10/health-management-3q-net-income-falls-5-percent

https://biosciencetechnology.com/news/2012/10/third-and-final-debate-final-face-2012-race-jordan-foils-terror-plot-police-domestic-violence-fueled-shooting-study

https://biosciencetechnology.com/news/2012/10/earnings-preview-aetna-reports-3q-thursday

https://biosciencetechnology.com/news/2012/10/ligand-pharma-getting-2m-payment-merck

https://biosciencetechnology.com/news/2012/10/lack-sleep-tied-teen-sports-injuries

https://biosciencetechnology.com/news/2012/10/natural-process-activates-brains-immune-cells-could-point-way-repairing-damaged-brain

https://biosciencetechnology.com/news/2012/10/researchers-discover-turbo-switch-calcium-pump-biological-cells

https://biosciencetechnology.com/news/2012/10/news-summary-pfizer-buying-adhd-drug-maker

https://biosciencetechnology.com/news/2012/10/stem-cell-bodyguards

https://biosciencetechnology.com/news/2012/10/immune-cells-make-flexible-choices

https://biosciencetechnology.com/news/2012/10/lilly-reports-late-stage-diabetes-drug-studies

https://biosciencetechnology.com/news/2012/10/iu-dance-theatre-celebrates-85th-anniversary-dynamic-concert

https://biosciencetechnology.com/news/2012/10/fda-approves-supernus-epilepsy-drug-oxtellar-xr

https://biosciencetechnology.com/news/2012/10/pfizer-will-buy-nextwave-pharma-700m

https://biosciencetechnology.com/news/2012/10/orexigen-talks-fda-speeding-contrave-review

https://biosciencetechnology.com/news/2012/10/edwards-lifesciences-lowers-2012-income-guidance

https://biosciencetechnology.com/news/2012/10/carper-carney-announce-46-million-cancer-research

https://biosciencetechnology.com/news/2012/10/earnings-schedule-week-10-22-2012

https://biosciencetechnology.com/news/2012/10/54-million-awarded-research-guide-alzheimers-drug-development

https://biosciencetechnology.com/news/2012/10/scientists-reveal-brain-circuitry-involved-post-traumatic-stress-and-related-disorders

https://biosciencetechnology.com/news/2012/10/depression-shortened-telomeres-increase-mortality-bladder-cancer-patients

https://biosciencetechnology.com/news/2012/10/webmd-extends-poison-pill-defense

https://biosciencetechnology.com/news/2012/10/avon-calling-faraway-towns

https://biosciencetechnology.com/news/2012/10/study-shows-reprogrammed-amniotic-fluid-cells-could-treat-vascular-diseases

https://biosciencetechnology.com/news/2012/10/first-micro-structure-atlas-human-brain-completed

https://biosciencetechnology.com/news/2012/10/blood-hormone-levels-can-predict-long-term-breast-cancer-risk

https://biosciencetechnology.com/news/2012/10/idexx-labs-3q-profit-climbs-11-pct-outlook-rises

https://biosciencetechnology.com/news/2012/10/lillys-amyvid-receives-european-endorsement

https://biosciencetechnology.com/news/2012/10/hospital-uses-lean-manufacturing-techniques-speed-stroke-care

https://biosciencetechnology.com/news/2012/10/cepheid-takes-3q-loss-after-patent-suit-settlement

https://biosciencetechnology.com/news/2012/10/cubist-income-rises-better-sales-lower-taxes

https://biosciencetechnology.com/news/2012/10/high-levels-estradiol-progesterone-during-pregnancy-associated-increased-risk-hr-negative-breast-cancer

https://biosciencetechnology.com/news/2012/10/firm-reaches-agreement-st-louis-area-site

https://biosciencetechnology.com/news/2012/10/antibiotic-resistance-growing-concern-urinary-tract-infection

https://biosciencetechnology.com/news/2012/10/isis-trading-halts-fda-reviews-key-drugs-risks

https://biosciencetechnology.com/news/2012/10/cancer-groups-improve-disclosures-pink-wares

https://biosciencetechnology.com/news/2012/10/better-way-prevent-blood-clots

https://biosciencetechnology.com/news/2012/10/genes-and-immune-system-shaped-childhood-poverty-stress

https://biosciencetechnology.com/news/2012/10/calcium-reveals-connections-between-neurons

https://biosciencetechnology.com/news/2012/10/biotime-makes-offer-geron-stem-cell-assets

https://biosciencetechnology.com/news/2012/10/hay-fever-asthma-combination-linked-lower-risk-death-colorectal-cancer

https://biosciencetechnology.com/news/2012/10/iu-researchers-discuss-ptsd-nerve-regeneration-balance-and-more-neuroscience-2012

https://biosciencetechnology.com/news/2012/10/iu-optometry-saving-sight-indiana-begin-partnership-improve-eye-care-states-underserved

https://biosciencetechnology.com/news/2012/10/labcorp-3q-profit-climbs-10-pct-forecast-narrows

https://biosciencetechnology.com/news/2012/10/stryker-pares-net-income-guidance-2012

https://biosciencetechnology.com/news/2012/10/clarification-earns-johnson-johnson-story

https://biosciencetechnology.com/news/2012/10/given-imaging-considers-sale-other-alternatives

https://biosciencetechnology.com/news/2012/10/two-components-red-meat-combined-alteration-dna-repair-increase-risk-bladder-cancer

https://biosciencetechnology.com/news/2012/10/renowned-einstein-immunologist-remembered

https://biosciencetechnology.com/news/2012/10/pbs-newshour-october-16-2012-part-1

https://biosciencetechnology.com/news/2012/10/abbott-labs-3q-profit-without-year-ago-charges

https://biosciencetechnology.com/news/2012/10/studies-report-early-childhood-trauma-takes-visible-toll-brain

https://biosciencetechnology.com/news/2012/10/your-brain-food-studies-reveal-how-diet-affects-brain-functions

https://biosciencetechnology.com/news/2012/10/findings-reveal-brain-mechanisms-work-during-sleep

https://biosciencetechnology.com/news/2012/10/increased-flavonoid-intake-reduced-risk-aggressive-prostate-cancer

https://biosciencetechnology.com/news/2012/10/medicaid-provider-terminate-contract-state

https://biosciencetechnology.com/news/2012/10/nabi-says-nicotine-vaccine-fails-again

https://biosciencetechnology.com/news/2012/10/education-about-risk-factors-both-cancer-and-cvd-led-increased-fruit-consumption-targeted-population

https://biosciencetechnology.com/news/2012/10/jack-cuzick-phd-honored-aacr-prevent-cancer-foundation-award-excellence-cancer-prevention-research

https://biosciencetechnology.com/news/2012/10/quest-diagnostics-3q-profit-falls-5-percent

https://biosciencetechnology.com/news/2012/10/pfizer-cancer-drug-narrowly-misses-study-goal

https://biosciencetechnology.com/news/2012/10/world-food-prize-activities-attract-occupy-protest

https://biosciencetechnology.com/news/2012/10/intuitive-surgical-3q-income-jumps-shares-slide

https://biosciencetechnology.com/news/2012/10/citigroup-ceo-quits-pandits-years-citigroup-earnings-boost-us-stocks-spain-bailout-hopes-european-stocks-europe-versus-us

https://biosciencetechnology.com/news/2012/10/pfizer-says-chantix-met-goals-depression-study

https://biosciencetechnology.com/news/2012/10/many-options-available-help-smokers-kick-habit

https://biosciencetechnology.com/news/2012/10/tenet-healthcare-closes-offering-800m-notes

https://biosciencetechnology.com/news/2012/10/money-october-15-2021-part-1

https://biosciencetechnology.com/news/2012/10/call-unitedhealth-ceo-stephen-j-hemsley

https://biosciencetechnology.com/news/2012/10/blood-yosemite-workers-could-advance-research

https://biosciencetechnology.com/news/2012/10/summary-box-unitedhealths-3q-profit-jumps-23-pct

https://biosciencetechnology.com/news/2012/10/stryker-buy-surpass-medical-least-100m

https://biosciencetechnology.com/news/2012/10/new-noninvasive-test-colorectal-cancer-shows-promise

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-16th-gtiv-hal-hek-hp

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-16th-isis-kr-lly-lmt

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-16th-lpl-mdco-now-osur

https://biosciencetechnology.com/news/2012/10/propthink-amed-sell-continue-no-reason-own-estimates-are-still-too-high

https://biosciencetechnology.com/news/2012/10/nps-shares-halted-fda-panel-reviews-bowel-drug

https://biosciencetechnology.com/news/2012/10/insurer-unitedhealths-3q-profit-jumps-23-percent

https://biosciencetechnology.com/news/2012/10/swiss-roche-posts-7-percent-rise-3q-drug-sales

https://biosciencetechnology.com/news/2012/10/cvs-pay-5m-settle-drug-pricing-allegations

https://biosciencetechnology.com/news/2012/10/american-heart-association-ceo-pays-tribute-senator-arlen-specter

https://biosciencetechnology.com/news/2012/10/jazz-pharma-completes-womens-health-unit-sale

https://biosciencetechnology.com/news/2012/10/icu-medical-3q-net-income-jumps-32-percent

https://biosciencetechnology.com/news/2012/10/propthink-abbots-impressive-hcv-data-continues-trend-everyones-got-candidate

https://biosciencetechnology.com/news/2012/10/celgene-downgraded-potential-acquisitions

https://biosciencetechnology.com/news/2012/10/american-association-cancer-research-mourns-loss-sen-arlen-specter-champion-cancer-research-and-biomedical-science

https://biosciencetechnology.com/news/2012/10/news-summary-abbott-labs-hepatitis-c-drug-study

https://biosciencetechnology.com/news/2012/10/abbott-labs-rises-hepatitis-c-drug-data

https://biosciencetechnology.com/news/2012/10/healthways-gets-tennessee-health-program-contract

https://biosciencetechnology.com/news/2012/10/einstein-establishes-paul-f-glenn-center-biology-human-aging-research

https://biosciencetechnology.com/news/2012/10/lilly-says-possible-cancer-drug-meets-study-goals

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-15th-isil-isrg-itri-ko

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-15th-omer-pgr-plce-pva

https://biosciencetechnology.com/news/2012/10/fda-accepts-depomeds-hot-flash-drug-review

https://biosciencetechnology.com/news/2012/10/fda-accepts-delcath-cancer-treatment-review

https://biosciencetechnology.com/news/2012/10/obesity-promotes-tumor-growth-regardless-diet

https://biosciencetechnology.com/news/2012/10/developing-brain-source-stability-and-instability-adolescence

https://biosciencetechnology.com/news/2012/10/new-research-reveals-more-about-how-brain-processes-facial-expressions-and-emotions

https://biosciencetechnology.com/news/2012/10/blood-cells-may-offer-telltale-clues-cancer-diagnosis

https://biosciencetechnology.com/news/2012/10/7-advisers-resign-embattled-texas-cancer-agency

https://biosciencetechnology.com/news/2012/10/mass-resignations-embattled-state-cancer-agency

https://biosciencetechnology.com/news/2012/10/earnings-schedule-week-10-15-2012

https://biosciencetechnology.com/news/2012/10/earnings-preview-unitedhealth-reports-3q-tues

https://biosciencetechnology.com/news/2012/10/analyst-downgrades-lilly-shares-underperform

https://biosciencetechnology.com/news/2012/10/celgene-gets-new-abraxane-marketing-approval

https://biosciencetechnology.com/news/2012/10/aeterna-zentaris-starts-15m-stock-offering

https://biosciencetechnology.com/news/2012/10/accuray-ceo-resigns-replaced-healthcare-exec

https://biosciencetechnology.com/news/2012/10/lexicon-pharma-rises-new-tumor-drug-data

https://biosciencetechnology.com/news/2012/10/propthink-diabetes-carcinoid-syndrome-drive-lexicons-late-stage-pipeline

https://biosciencetechnology.com/news/2012/10/fda-extends-review-impax-labs-parkinsons-drug

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-12th-ge-goog-grpn-gww

https://biosciencetechnology.com/news/2012/10/propthink-fresh-look-kerx-high-odds-zerenex-phase-iii-success

https://biosciencetechnology.com/news/2012/10/quest-diagnostics-cutting-400-600-jobs

https://biosciencetechnology.com/news/2012/10/rare-genetic-disorder-provides-clues-about-schizophrenia

https://biosciencetechnology.com/news/2012/10/research-team-scores-advance-manipulating-t-cells

https://biosciencetechnology.com/news/2012/10/superbugs-ride-air-currents-around-hospital-wards

https://biosciencetechnology.com/news/2012/10/exercise-could-fortify-immune-system-against-future-cancers

https://biosciencetechnology.com/news/2012/10/minutes-hard-exercise-can-lead-all-day-calorie-burn

https://biosciencetechnology.com/news/2012/10/dna-confirms-genetically-distinct-lion-population-ethiopia

https://biosciencetechnology.com/news/2012/10/cantel-medical-4q-net-income-more-doubles

https://biosciencetechnology.com/news/2012/10/prospective-alzheimers-drug-builds-new-brain-cell-connections

https://biosciencetechnology.com/news/2012/10/filming-bacterial-life-multicolor-new-diagnostic-and-antibiotic-discovery-tool

https://biosciencetechnology.com/news/2012/10/scientists-pinpoint-gene-variations-linked-higher-risk-bipolar-disorder

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-11th-slf-slm-sm-snn

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-11th-ofc-ois-one-onxx

https://biosciencetechnology.com/news/2012/10/brain-scans-can-predict-childrens-reading-ability

https://biosciencetechnology.com/news/2012/10/aacr-ceo-dr-margaret-foti-receive-national-brain-tumor-society-founders-award-excellence-cancer-research

https://biosciencetechnology.com/news/2012/10/criteria-used-diagnose-sports-head-injuries-found-be-inconsistent

https://biosciencetechnology.com/news/2012/10/dentsply-international-schedules-third-quarter-fiscal-2012-earnings-release-and-conference-call

https://biosciencetechnology.com/news/2012/10/perrigo-gets-fda-ok-sell-nicotine-lozenges

https://biosciencetechnology.com/news/2012/10/edwards-lifesciences-buys-blood-monitoring-company

https://biosciencetechnology.com/news/2012/10/propthink-fda-warning-letter-weakens-shares-akorn

https://biosciencetechnology.com/news/2012/10/positive-test-california-squirrel-exposed-plague-bacteria

https://biosciencetechnology.com/news/2012/10/scientists-devise-new-screening-method-aid-rna-drug-development-research

https://biosciencetechnology.com/news/2012/10/study-shows-vitamin-c-prevents-bone-loss-animal-models

https://biosciencetechnology.com/news/2012/10/synthetic-liver-enzyme-could-result-more-effective-drugs-fewer-side-effects

https://biosciencetechnology.com/news/2012/10/how-cancer-cells-break-free-tumors

https://biosciencetechnology.com/news/2012/10/glowing-dna-invention-points-towards-high-speed-disease-detection

https://biosciencetechnology.com/news/2012/10/equity-brief-ratings-changes-october-10th-avb-bah-biib-cce

https://biosciencetechnology.com/news/2012/10/becton-dickinson-cfo-go-temporary-exec-named

https://biosciencetechnology.com/news/2012/10/aacr-and-university-catania-honored-dr-silvia-caggia-third-margaret-foti-award

https://biosciencetechnology.com/news/2012/10/analyst-downgrades-johnson-johnson-sell

https://biosciencetechnology.com/news/2012/10/matrixx-initiatives-raises-prophase-buyout-offer

https://biosciencetechnology.com/news/2012/10/kids-weight-loss-program-being-introduced-la

https://biosciencetechnology.com/news/2012/10/propthink-qcor-posts-positive-script-trends-acthar-analyst-comes-back-around

https://biosciencetechnology.com/news/2012/10/bitter-taste-receptors-regulate-upper-respiratory-defense-system

https://biosciencetechnology.com/news/2012/10/scientists-develop-barcode-blood-test-aggressive-prostate-cancer

https://biosciencetechnology.com/news/2012/10/scientists-identify-biological-mechanism-plays-key-role-early-onset-dementia

https://biosciencetechnology.com/news/2012/10/gene-bursting-plays-key-role-protein-production

https://biosciencetechnology.com/news/2012/10/can-eating-tomatoes-lower-risk-stroke

https://biosciencetechnology.com/news/2012/10/stand-cancer-and-prostate-cancer-foundation-announce-second-research-dream-team

https://biosciencetechnology.com/news/2012/10/merck-moving-its-global-headquarters

https://biosciencetechnology.com/news/2012/10/accelrys-announces-2012-us-tech-summit-it-professionals

https://biosciencetechnology.com/news/2012/10/amicus-therapeutics-could-double-positive-phase-3-data

https://biosciencetechnology.com/news/2012/10/nc-settles-medicaid-fraud-case-against-abbott

https://biosciencetechnology.com/news/2012/10/analyst-expects-strong-demand-cerus-systems

https://biosciencetechnology.com/news/2012/10/spectrum-pharm-says-folotyn-patent-extended

https://biosciencetechnology.com/news/2012/10/affymetrix-expects-3q-revenue-below-streets-view

https://biosciencetechnology.com/news/2012/10/news-summary-unitedhealth-plans-49b-acquisition

https://biosciencetechnology.com/news/2012/10/aacr-appoints-patrice-j-morin-phd-director-scientific-review-and-grants-administration

https://biosciencetechnology.com/news/2012/10/fresh-blood-not-better-clinical-trial-shows

https://biosciencetechnology.com/news/2012/10/sleeping-brain-behaves-if-its-remembering-something

https://biosciencetechnology.com/news/2012/10/mosquito-genetics-may-offer-clues-malaria-control

https://biosciencetechnology.com/news/2012/10/engineers-examine-uv-effects-skin-mechanics

https://biosciencetechnology.com/news/2012/10/carefusion-agrees-buy-intermed-brazil

https://biosciencetechnology.com/news/2012/10/nobel-prize-briton-japanese-stem-cell-work

https://biosciencetechnology.com/news/2012/10/unitedhealth-plans-intl-growth-49b-deal

https://biosciencetechnology.com/news/2012/10/cel-sci-ceo-defends-lead-drugs-lengthy-development-timeline-hints-big-upcoming-catalyst

https://biosciencetechnology.com/news/2012/10/recent-winners-nobel-prize-medicine

https://biosciencetechnology.com/news/2012/10/us-initiative-will-test-appetite-gmo-food

https://biosciencetechnology.com/news/2012/10/calif-initiative-will-test-appetite-gmo-food

https://biosciencetechnology.com/news/2012/10/propthink-oxford-continues-cover-qcors-acthar-sales-look-much-more-stable-now

https://biosciencetechnology.com/news/2012/10/toward-artificial-pancreas-math-modeling-and-diabetes-control

https://biosciencetechnology.com/news/2012/10/researchers-find-electricity-biological-clock

https://biosciencetechnology.com/news/2012/10/new-gene-test-detects-early-mouth-cancer-risk

https://biosciencetechnology.com/news/2012/10/researchers-create-universal-map-vision-human-brain

https://biosciencetechnology.com/news/2012/10/scientists-explain-how-ketamine-vanquishes-depression-within-hours

https://biosciencetechnology.com/news/2012/10/avon-products-chairman-step-down

https://biosciencetechnology.com/news/2012/10/medtronic-launches-new-angioplasty-catheter-below-knee-arteries

https://biosciencetechnology.com/news/2012/10/medtronic-completes-enrollment-landmark-study-inpact-drug-eluting-balloon-peripheral-artery-disease

https://biosciencetechnology.com/news/2012/10/law-firm-wohl-fruchter-llp-announces-investigation-amyris-inc

https://biosciencetechnology.com/news/2012/10/butte-parents-sue-over-babys-heart-defect

https://biosciencetechnology.com/news/2012/10/minn-lawmakers-want-lou-gehrigs-medical-records

https://biosciencetechnology.com/news/2012/10/collabrx-teaming-life-technologies

https://biosciencetechnology.com/news/2012/10/biosante-will-merge-ani-pharma-stock-deal

https://biosciencetechnology.com/news/2012/10/not-getting-sleepy-research-explains-why-hypnosis-doesnt-work-all

https://biosciencetechnology.com/news/2012/10/chewing-ability-linked-reduced-dementia-risk

https://biosciencetechnology.com/news/2012/10/ensuring-high-quality-dietary-supplements-quality-design

https://biosciencetechnology.com/news/2012/10/new-study-links-caffeinated-coffee-vision-loss

https://biosciencetechnology.com/news/2012/10/nih-grant-fund-novel-approach-reducing-chlamydia-rates-women

https://biosciencetechnology.com/news/2012/10/new-study-demonstrates-superior-clinical-and-quality-life-benefits-medtronic-sacral-neuromodulation-compared-standard-medical-treatment-overactive-bladder-six-month

https://biosciencetechnology.com/news/2012/10/celgene-says-fda-panel-wont-review-pomalidomide

https://biosciencetechnology.com/news/2012/10/profs-aim-track-drug-reactions-social-media

https://biosciencetechnology.com/news/2012/10/some-women-genes-may-influence-pressure-be-thin

https://biosciencetechnology.com/news/2012/10/acoustic-cell-sorting-chip-may-lead-cell-phone-sized-medical-labs

https://biosciencetechnology.com/news/2012/10/study-suggests-immune-system-can-boost-regeneration-peripheral-nerves

https://biosciencetechnology.com/news/2012/10/rare-disease-researchers-notch-win-patients-inherited-muscle-disease

https://biosciencetechnology.com/news/2012/10/bristol-myers-sanofi-revamp-plavix-sales-alliance

https://biosciencetechnology.com/news/2012/10/people-schizophrenia-more-likely-die-heart-attack

https://biosciencetechnology.com/news/2012/10/sarepta-shares-soar-muscular-dystrophy-study

https://biosciencetechnology.com/news/2012/10/shares-rigel-pharma-fall-stock-offering

https://biosciencetechnology.com/news/2012/10/opko-health-setting-big-short-squeeze

https://biosciencetechnology.com/news/2012/10/theravance-partnership-gastroparesis-drug

https://biosciencetechnology.com/news/2012/10/intermune-says-canada-approves-lung-disease-drug

https://biosciencetechnology.com/news/2012/10/antares-shares-fall-planned-stock-sale

https://biosciencetechnology.com/news/2012/10/aacr-awards-senator-sherrod-brown-2012-distinguished-public-service-award

https://biosciencetechnology.com/news/2012/10/covidien-completes-100m-cns-therapeutics-deal

https://biosciencetechnology.com/news/2012/10/federal-court-oks-15b-abbott-labs-settlement

https://biosciencetechnology.com/news/2012/10/davita-says-federal-investigation-complete

https://biosciencetechnology.com/news/2012/10/celgene-edges-higher-abraxane-melanoma-study

https://biosciencetechnology.com/news/2012/10/arqule-stock-plunges-lung-cancer-study-shelved

https://biosciencetechnology.com/news/2012/10/cell-therapeutics-rises-orphan-drug-decision

https://biosciencetechnology.com/news/2012/10/florida-gets-9-million-study-citrus-disease

https://biosciencetechnology.com/news/2012/10/uic-gets-money-study-childhood-obesity-factors

https://biosciencetechnology.com/news/2012/10/propthink-tivantinib-will-not-meet-primary-endpoint-phase-iii-trial-discontinued

https://biosciencetechnology.com/news/2012/10/new-antibiotic-cures-disease-disarming-pathogens-not-killing-them

https://biosciencetechnology.com/news/2012/10/researchers-harness-immune-system-improve-stem-cell-transplant-outcomes

https://biosciencetechnology.com/news/2012/10/omega-3-supplements-may-slow-biological-effect-aging

https://biosciencetechnology.com/news/2012/10/new-data-reinforce-positive-clinical-outcomes-direct-aortic-implants-using-medtronic-corevalve-system

https://biosciencetechnology.com/news/2012/10/petsmart-replace-sunoco-benchmark-s-p-500

https://biosciencetechnology.com/news/2012/10/johnson-johnson-expands-puerto-rico-factories

https://biosciencetechnology.com/news/2012/10/threshold-slumps-despite-brain-cancer-drug-data

https://biosciencetechnology.com/news/2012/10/west-pharmaceutical-boosts-dividend

https://biosciencetechnology.com/news/2012/10/misconduct-not-error-accounts-most-scientific-paper-retractions

https://biosciencetechnology.com/news/2012/10/accelrys-strengthens-leadership-team-appointment-new-senior-vice-president-marketing-product-management-and-corporate-development

https://biosciencetechnology.com/news/2012/10/us-postal-service-default-second-5-billion-payment-wsj-amazon-planning-online-wine-sales-israeli-prime-minister-netanyahu-says

https://biosciencetechnology.com/news/2012/10/new-publication-supports-early-diagnosis-children-autism-spectrum

https://biosciencetechnology.com/news/2012/10/how-memory-load-leaves-us-blind-new-visual-information

https://biosciencetechnology.com/news/2012/10/children-underrepresented-drug-studies

https://biosciencetechnology.com/news/2012/10/blocking-key-protein-could-halt-age-related-decline-immune-system

https://biosciencetechnology.com/news/2012/10/stryker-picks-orthopedics-head-lobo-new-ceo

https://biosciencetechnology.com/news/2012/10/apricus-will-seek-canadian-mycova-approval-2013

https://biosciencetechnology.com/news/2012/10/scientists-find-missing-link-between-players-epigenetic-code

https://biosciencetechnology.com/news/2012/10/novel-pathogen-epidemic-identified-sub-saharan-africa

https://biosciencetechnology.com/news/2012/10/study-questions-association-between-common-heartburn-drugs-and-risk-pneumonia

https://biosciencetechnology.com/news/2012/10/medtronic-initiates-first-clinical-trial-symplicitytm-renal-denervation-system-treatment-resistant-hypertension-japan

https://biosciencetechnology.com/news/2012/10/buffetts-firm-boosts-stake-davita-over-10-pct

https://biosciencetechnology.com/news/2012/10/combination-targeted-treatment-drugs-delays-resistance-melanoma-patients

https://biosciencetechnology.com/news/2012/10/propthink-sickle-cell-drug-finding-new-opportunity-adventrx-pharmaceuticals

https://biosciencetechnology.com/news/2012/10/stryker-names-kevin-lobo-president-and-chief-executive-officer

https://biosciencetechnology.com/news/2012/09/noninvasive-measurement-enables-use-interstitial-fluid-pressure-potential-biomarker-tumor-aggressiveness

https://biosciencetechnology.com/news/2012/11/accelrys-materials-studio-release-61-speeds-innovation-enterprise-capabilities

https://biosciencetechnology.com/news/2012/11/eu-agency-number-synthetic-drugs-keeps-rising

https://biosciencetechnology.com/news/2012/11/measurement-and-interpretation-ankle-brachial-index-scientific-statement-american-heart-association

https://biosciencetechnology.com/news/2012/11/ap-top-health-news-539-am-est

https://biosciencetechnology.com/news/2012/11/dutch-hospital-lead-organ-trafficking-probe

https://biosciencetechnology.com/news/2012/11/multibillion-dollar-health-fund-fires-watchdog

https://biosciencetechnology.com/news/2012/11/bp-near-settlement-us-over-gulf-spill

https://biosciencetechnology.com/news/2012/11/scores-isolated-after-new-ebola-outbreak-uganda

https://biosciencetechnology.com/news/2012/11/potential-new-technique-anticancer-radiotherapy-could-provide-alternative-brachytherapy

https://biosciencetechnology.com/news/2012/11/ap-top-science-news-8-pm-est

https://biosciencetechnology.com/news/2012/11/president-obama-begin-two-days-fiscal-cliff-meetings-morning-transunion-late-payment-rate-mortgages-fell-3q-last

https://biosciencetechnology.com/news/2012/11/pbs-newshour-november-13-2012-part-2

https://biosciencetechnology.com/news/2012/11/heart-failure-older-breast-cancer-patients-linked-medication

https://biosciencetechnology.com/news/2012/11/carbon-nanotubes-may-protect-dna-oxidation

https://biosciencetechnology.com/news/2012/11/brain-waves-make-waves

https://biosciencetechnology.com/news/2012/11/smoking-affects-allergy-relevant-stem-cells

https://biosciencetechnology.com/news/2012/11/triclosan-cosmetics-and-personal-care-products-can-increase-allergy-risk

https://biosciencetechnology.com/news/2012/11/pancreas-stem-cell-discovery-may-lead-new-diabetes-treatments

https://biosciencetechnology.com/news/2012/11/eu-oks-bristol-myers-astrazeneca-diabetes-drug

https://biosciencetechnology.com/news/2012/11/winners-announced-national-kids-hip-hop-video-competition

https://biosciencetechnology.com/news/2012/11/study-finds-high-exposure-food-borne-toxins

https://biosciencetechnology.com/news/2012/11/new-brain-gene-born-study-shows

https://biosciencetechnology.com/news/2012/11/ancient-foot-massage-technique-may-ease-cancer-symptoms

https://biosciencetechnology.com/news/2012/11/ap-top-health-news-1130-am-est

https://biosciencetechnology.com/news/2012/11/durata-therapeutics-moving-nj-illinois

https://biosciencetechnology.com/news/2012/11/migraine-associated-brain-changes-not-related-impaired-cognition

https://biosciencetechnology.com/news/2012/11/stem-cell-finding-could-advance-immunotherapy-lung-cancer

https://biosciencetechnology.com/news/2012/11/ireland-probes-death-ill-abortion-seeker

https://biosciencetechnology.com/news/2012/11/ap-top-health-news-738-am-est

https://biosciencetechnology.com/news/2012/11/un-says-access-contraception-human-right

https://biosciencetechnology.com/news/2012/11/croatia-opens-health-fraud-probe-against-76-people

https://biosciencetechnology.com/news/2012/11/ap-top-science-news-1035-pm-est

https://biosciencetechnology.com/news/2012/11/meditation-may-reduce-death-heart-attack-and-stroke-heart-patients

https://biosciencetechnology.com/news/2012/11/deadly-california-mushrooms-came-backyard

https://biosciencetechnology.com/news/2012/11/astrazeneca-german-court-voids-seroquel-xr-patent

https://biosciencetechnology.com/news/2012/11/cigna-says-it-won-il-medicare-medicaid-contract

https://biosciencetechnology.com/news/2012/11/ex-univ-minnesota-social-worker-sanctioned

https://biosciencetechnology.com/news/2012/11/edwards-says-court-upheld-medtronic-patent-ruling

https://biosciencetechnology.com/news/2012/11/november-12-2012-nbc-part-1

https://biosciencetechnology.com/news/2012/11/analysts-tout-advantage-gilead-hepatitis-c-drug

https://biosciencetechnology.com/news/2012/11/merck-ends-development-januvia-lipitor-combo

https://biosciencetechnology.com/news/2012/11/american-heart-association-adds-new-ingredients-simple-cooking-heart-program

https://biosciencetechnology.com/news/2012/11/glutamate-neurotransmission-system-may-be-involved-depression-risk

https://biosciencetechnology.com/news/2012/11/gene-sequencing-project-identifies-abnormal-gene-launches-rare-childhood-leukemia

https://biosciencetechnology.com/news/2012/11/generic-competition-grows-pfizers-revatio

https://biosciencetechnology.com/news/2012/11/propthink-can-patients-scoop-clinical-trial-results

https://biosciencetechnology.com/news/2012/11/olympus-investors-seek-240-million-compensation

https://biosciencetechnology.com/news/2012/11/tiny-tekmira-lands-65m-settlement-plus-10m-near-term-milestone-payments-alnylam

https://biosciencetechnology.com/news/2012/11/clouds-may-ruin-trip-eclipse-fans-australia

https://biosciencetechnology.com/news/2012/11/ap-top-science-news-1253-am-est

https://biosciencetechnology.com/news/2012/11/perkinelmer-buys-chinese-test-developer-38m

https://biosciencetechnology.com/news/2012/11/dr-judy-aschner-named-chair-pediatrics-department-montefiore-medical-center-and-einstein

https://biosciencetechnology.com/news/2012/11/fda-finds-contamination-issues-ameridose

https://biosciencetechnology.com/news/2012/11/humana-gets-ill-medicare-medicaid-contract

https://biosciencetechnology.com/news/2012/11/healthcare-movers-gilead-sciences-clovis-oncology-pluristem-vivus-idenix-pharmaceuticals-achillion-pharmaceuticals

https://biosciencetechnology.com/news/2012/11/vivus-says-qsymia-ingredients-help-sleep-apnea

https://biosciencetechnology.com/news/2012/11/meditation-appears-produce-enduring-changes-emotional-processing-brain

https://biosciencetechnology.com/news/2012/11/combination-pi3-kinase-and-parp-inhibitors-may-offer-new-treatment-option-triple-negative-breast-cancers

https://biosciencetechnology.com/news/2012/11/new-mechanism-action-parp-inhibitors-discovered

https://biosciencetechnology.com/news/2012/11/analysts-lowers-rating-j-j-hold-buy

https://biosciencetechnology.com/news/2012/11/abbott-releases-humira-data-back-disease

https://biosciencetechnology.com/news/2012/11/detection-analysis-cell-dust-may-allow-diagnosis-monitoring-brain-cancer

https://biosciencetechnology.com/news/2012/11/american-academy-optometry-recognizes-two-iu-distinguished-careers

https://biosciencetechnology.com/news/2012/11/watson-sell-generic-version-pfizers-revatio

https://biosciencetechnology.com/news/2012/11/expert-time-break-beta-blocker-habit

https://biosciencetechnology.com/news/2012/11/research-team-finds-two-genetic-flaws-behind-third-most-common-form-inherited-muscular-dystrophy

https://biosciencetechnology.com/news/2012/11/its-not-just-what-you-eat-when-you-eat-it-study-shows-link-between-fat-cell-and-brain-clock-molecules

https://biosciencetechnology.com/news/2012/11/early-stress-may-sensitize-girls-brains-later-anxiety

https://biosciencetechnology.com/news/2012/11/propthink-galena-one-biotechs-most-vulnerable-names

https://biosciencetechnology.com/news/2012/11/british-medical-journal-slams-roche-tamiflu

https://biosciencetechnology.com/news/2012/11/2-calif-deaths-mushrooms-despite-warnings

https://biosciencetechnology.com/news/2012/11/food-labels-multiply-some-confuse-consumers

https://biosciencetechnology.com/news/2012/11/ap-top-health-news-10-am-est

https://biosciencetechnology.com/news/2012/11/gi-5005-improves-virologic-clearance-hcv-combination-pegifn-ribavirin-il28b-t-t-patients

https://biosciencetechnology.com/news/2012/11/gi-13020-tarmogen%C2%AE-treatment-chronic-hepatitis-b-generates-antigen-specific-t-cell-responses-key-preclinical-studies

https://biosciencetechnology.com/news/2012/11/us-computer-graphics-scientist-wins-kyoto-prize

https://biosciencetechnology.com/news/2012/11/ap-top-science-news-352-am-est

https://biosciencetechnology.com/news/2012/11/myrexis-board-approves-plan-dissolve-company

https://biosciencetechnology.com/news/2012/11/illinois-selects-8-managed-care-companies

https://biosciencetechnology.com/news/2012/11/ap-top-health-news-430-pm-est

https://biosciencetechnology.com/news/2012/11/meningitis-outbreak-toll-438-cases-32-deaths

https://biosciencetechnology.com/news/2012/11/sequenom-jumps-down-syndrome-test-outlook

https://biosciencetechnology.com/news/2012/11/propthink-mark-calendar-celsion-release-thermodox-trial-results-january

https://biosciencetechnology.com/news/2012/11/warner-chilcott-3q-net-income-more-triples

https://biosciencetechnology.com/news/2012/11/antioxidants-may-ease-pad-blood-pressure-increase

https://biosciencetechnology.com/news/2012/11/more-bang-biofuel-buck

https://biosciencetechnology.com/news/2012/11/covidien-fiscal-4q-net-income-rises-2-pct

https://biosciencetechnology.com/news/2012/11/propthink-biogen-idec-rfviiifc-trials-somewhat-disappointing-als-trials-could-be-next-catalyst

https://biosciencetechnology.com/news/2012/11/italian-cardiologists-arrested-over-experiments

https://biosciencetechnology.com/news/2012/11/official-backs-studying-quake-risks-nuke-plants

https://biosciencetechnology.com/news/2012/11/nzealand-beaching-proves-rarest-whales-exists

https://biosciencetechnology.com/news/2012/11/new-zealand-wont-sign-kyoto-2-climate-treaty

https://biosciencetechnology.com/news/2012/11/geologists-find-east-coast-quakes-travel-farther

https://biosciencetechnology.com/news/2012/11/ap-top-science-news-2-am-est

https://biosciencetechnology.com/news/2012/11/child-disease-cases-vietnam-fatalities-down

https://biosciencetechnology.com/news/2012/11/layoffs-firm-tied-mass-pharmacy-outbreak

https://biosciencetechnology.com/news/2012/11/calif-city-plans-provide-transgender-surgeries

https://biosciencetechnology.com/news/2012/11/fda-panel-votes-8-4-novo-nordisk-diabetes-drug

https://biosciencetechnology.com/news/2012/11/healthcare-review-dusa-pharmaceuticals-intermune-tekmira-bioscrip-repligen-corporation-orasure-are-notable-movers

https://biosciencetechnology.com/news/2012/11/ap-top-health-news-1245-pm-est

https://biosciencetechnology.com/news/2012/11/fda-reviewing-mercks-experimental-insomnia-drug

https://biosciencetechnology.com/news/2012/11/gene-find-turns-soldier-beetle-defence-biotech-opportunity

https://biosciencetechnology.com/news/2012/11/research-reveals-new-aspect-platelet-behavior-heart-attacks-clots-can-sense-blood-flow

https://biosciencetechnology.com/news/2012/11/sugar-boosts-self-control

https://biosciencetechnology.com/news/2012/11/measuring-metabolism-can-predict-progress-alzheimers-90-accuracy

https://biosciencetechnology.com/news/2012/11/new-cell-type-developed-possible-treatment-alzheimers-and-other-brain-diseases

https://biosciencetechnology.com/news/2012/11/sun-pharmaceutical-buy-dusa-deal-worth-230m

https://biosciencetechnology.com/news/2012/11/propthink-big-catalysts-approaching-trius-therapeutics

https://biosciencetechnology.com/news/2012/11/propthink-endocyte-safe-bet-2013

https://biosciencetechnology.com/news/2012/11/stryker-announces-changes-executive-leadership

https://biosciencetechnology.com/news/2012/11/uk-police-open-inquiry-breast-cancer-surgeon

https://biosciencetechnology.com/news/2012/11/obamas-health-care-overhaul-turns-sprint

https://biosciencetechnology.com/news/2012/11/rethinking-body-mass-index-bmi-assessing-cancer-risk

https://biosciencetechnology.com/news/2012/11/wednesday-news-tips-november-7-2012

https://biosciencetechnology.com/news/2012/11/schein-3q-income-rises-animal-health-revenue

https://biosciencetechnology.com/news/2012/11/mass-pharmacy-board-director-fired

https://biosciencetechnology.com/news/2012/11/ariad-takes-bigger-3q-loss-cancer-drug-costs

https://biosciencetechnology.com/news/2012/11/auxilium-tumbles-drug-marketing-deal-ends

https://biosciencetechnology.com/news/2012/11/propthink-what-vivus-and-arenas-earnings-mean-orexigen

https://biosciencetechnology.com/news/2012/11/meningitis-outbreak-toll-424-cases-31-deaths

https://biosciencetechnology.com/news/2012/11/summary-box-wellpoint-3q-profit-stock-down

https://biosciencetechnology.com/news/2012/11/experts-raise-concerns-over-superhuman-workplace

https://biosciencetechnology.com/news/2012/11/ap-top-health-news-112-pm-est

https://biosciencetechnology.com/news/2012/11/tenet-healthcare-rises-3q-and-election-results

https://biosciencetechnology.com/news/2012/11/perrigos-shares-fall-weak-1q-revenue

https://biosciencetechnology.com/news/2012/11/protein-reveals-diabetes-risk-many-years-advance

https://biosciencetechnology.com/news/2012/11/propthink-management-says-ariad-well-prepared-ponatinib-launch

https://biosciencetechnology.com/news/2012/11/propthink-acadias-value-heavily-dependent-pimavanserin-data

https://biosciencetechnology.com/news/2012/11/rebuilding-whole-heart-children-born-only-half-one

https://biosciencetechnology.com/news/2012/11/insurer-wellpoints-3q-net-income-edges-higher

https://biosciencetechnology.com/news/2012/11/how-much-salt-are-you-eating-beware-sodium-these-salty-six-foods

https://biosciencetechnology.com/news/2012/11/inflammation-marker-linked-increased-risk-death-cancer-korean-men

https://biosciencetechnology.com/news/2012/11/ultrafiltration-may-not-be-best-approach-heart-failure-patients

https://biosciencetechnology.com/news/2012/11/amyris-trims-3q-loss-lower-operating-costs

https://biosciencetechnology.com/news/2012/11/news-summary-pfizer-rheumatoid-arthritis-drug

https://biosciencetechnology.com/news/2012/11/calif-considers-labeling-requirement-gmo-food

https://biosciencetechnology.com/news/2012/11/pfizer-says-fda-approves-arthritis-drug-xeljanz

https://biosciencetechnology.com/news/2012/11/news-summary-cvs-caremark-3q-profit-16-pct

https://biosciencetechnology.com/news/2012/11/ap-top-health-news-319-pm-est

https://biosciencetechnology.com/news/2012/11/drug-trio-improved-effectiveness-cancer-treatment-protected-heart

https://biosciencetechnology.com/news/2012/11/mgh-mit-study-discovers-how-brain-activity-changes-when-anesthesia-induces-unconsciousness

https://biosciencetechnology.com/news/2012/11/therapy-bone-marrow-derived-stem-cells-does-not-improve-short-term-recovery-after-heart-attack

https://biosciencetechnology.com/news/2012/11/healthy-living-adds-14-years-your-life

https://biosciencetechnology.com/news/2012/11/study-identifies-superbug-mrsa-us-wastewater-treatment-plants

https://biosciencetechnology.com/news/2012/11/equity-brief-ratings-changes-november-6th-abmd-acor-adt-aiv-amba-amsf-asei-avd-banr

https://biosciencetechnology.com/news/2012/11/equity-brief-ratings-changes-november-6th-dlph-dnkn-dva-dvax-dvn-endp-enr-eqix-esrx

https://biosciencetechnology.com/news/2012/11/equity-brief-ratings-changes-november-6th-jmba-kmp-krft-life-lnkd-lrcx-lsi-mdf-mdlz

https://biosciencetechnology.com/news/2012/11/equity-brief-ratings-changes-november-6th-scor-sial-sltm-srev-stx-tdc-teso-teva-tjx

https://biosciencetechnology.com/news/2012/11/equity-brief-ratings-changes-november-6th-pva-r-rgld-rigl-rjet-rkt-rl-rost-rsg

https://biosciencetechnology.com/news/2012/11/equity-brief-ratings-changes-november-6th-oxy-panw-pcyc-pdce-pds-pnr-pnw-pps-prov

https://biosciencetechnology.com/news/2012/11/propthink-pfizer-spooks-durect-investors-creates-opportunity

https://biosciencetechnology.com/news/2012/11/cvs-caremark-3q-profit-16-pct-sales-rise

https://biosciencetechnology.com/news/2012/11/amedisys-reports-third-quarter-financial-results

https://biosciencetechnology.com/news/2012/11/monday-news-tips-november-5-2012

https://biosciencetechnology.com/news/2012/11/news-summary-express-scripts-profit-rises-3q

https://biosciencetechnology.com/news/2012/11/life-technologies-buys-advanced-microscopy-group

https://biosciencetechnology.com/news/2012/11/health-net-climbs-california-settlement

https://biosciencetechnology.com/news/2012/11/express-scripts-profit-rises-21-percent-3rd-qtr

https://biosciencetechnology.com/news/2012/11/november-4-2012-cbs

https://biosciencetechnology.com/news/2012/11/limits-class-action-lawsuits-supreme-court

https://biosciencetechnology.com/news/2012/11/reactions-everyday-stressors-predict-future-health

https://biosciencetechnology.com/news/2012/11/daily-dose-new-probiotic-reduces-bad-and-total-cholesterol

https://biosciencetechnology.com/news/2012/11/summary-box-humana-reports-3rd-qtr-results

https://biosciencetechnology.com/news/2012/11/propthink-geron-q3-earnings-review-waiting-not-godot-san-antonio-and-atlanta

https://biosciencetechnology.com/news/2012/11/humana-posts-lower-3rd-qtr-profit

https://biosciencetechnology.com/news/2012/11/inc-research-discusses-benefits-involving-cros-early-planning-partnerships-clinical-trials-2012

https://biosciencetechnology.com/news/2012/11/bypass-surgery-more-cost-effective-stents-diabetics-long-term

https://biosciencetechnology.com/news/2012/11/bypass-surgery-significantly-better-stents-treating-multiple-blockages-diabetics

https://biosciencetechnology.com/news/2012/11/alternative-therapy-produces-intriguing-results-some-heart-patients-many-questions-remain

https://biosciencetechnology.com/news/2012/11/surgery-seems-best-heart-disease-diabetics

https://biosciencetechnology.com/news/2012/11/warren-buffetts-firm-buys-more-davita-stock

https://biosciencetechnology.com/news/2012/11/people-crowdsourcing-challenge-find-defibrillators-philadelphia

https://biosciencetechnology.com/news/2012/11/new-studies-reinforce-american-heart-associations-stand-limiting-sodium

https://biosciencetechnology.com/news/2012/11/fda-oks-expanded-uses-xarelto-blood-thinner

https://biosciencetechnology.com/news/2012/11/earnings-schedule-week-11-5-2012

https://biosciencetechnology.com/news/2012/11/propthink-vertex-earnings-demonstrate-inciveks-short-lived-stardom

https://biosciencetechnology.com/news/2012/11/earnings-preview-cvs-caremark-reports-3q-tues

https://biosciencetechnology.com/news/2012/11/orthofix-paying-30m-settle-kickbacks-case

https://biosciencetechnology.com/news/2012/11/enzo-biochem-jumps-jury-award-patent-lawsuit

https://biosciencetechnology.com/news/2012/11/dendreon-jumps-stronger-3q-provenge-sales

Pages